XML 39 R10.htm IDEA: XBRL DOCUMENT v3.2.0.727
Notes Payable
6 Months Ended
Jun. 30, 2015
Notes Payable  
Notes Payable

5. Notes Payable

 

In April 2014, we borrowed $2.0 million in connection with a term loan pursuant to a Loan and Security Agreement (LSA) we entered into with a financial institution. Pursuant to the terms of the LSA, we made monthly interest-only payments for outstanding borrowings at an interest rate equal to the greater of (a) prime plus 2.25% or (b) 5.5% until the LSA was amended in December 2014.

 

In December 2014, we entered into a First Amendment to Loan and Security Agreement (Amended LSA) with the same financial institution.  The Amended LSA increased the total term loan availability from $2.0 million to $12.0 million, available in four tranches (in thousands):

 

 

 

 

 

 

 

 

 

 

 

Term Loan

 

 

Term Loan

 

 

Tranche

 

Available

 

 

Borrowed

 

Borrowed Date

A

$

2,000

 

$

2,000

 

April 2014

B

 

5,000

 

 

5,000

 

December 2014

C

 

2,500

 

 

 

*

D

 

2,500

 

 

 

*

 

$

12,000

 

$

7,000

 

 

*Our ability to borrow under the remaining tranches of $2.5 million each depends upon meeting certain clinical trial milestones.  The availability end dates of Tranches C and D are September 1, 2015 and March 31, 2016, respectively.

 

In connection with the Amended LSA, we borrowed $5.0 million available to us under Tranche B in December 2014.  Pursuant to the terms of the Amended LSA, we are required to make monthly interest-only payments for all outstanding borrowings at an interest rate equal to the greater of (a) prime rate plus 3.5% or (b) 6.5% until December 2015.  Commencing in January 2016 and continuing through December 2017, we are required to make monthly payments of payments of 1/24th of our principal borrowings plus interest.  If we achieve certain clinical trial milestones by August 2015, both the interest-only period and principal maturity date will be extended by six months.

 

As of June 30, 2015, of our outstanding term loan balance of $7.0 million, $1.8 million will be due within the next twelve months, and is classified as the current portion of long-term debt on our balance sheet.  Interest expense related to the term loans was $117 thousand and $232 thousand for the three and six months ended June 30, 2015, respectively.  As of June 30, 2015, we had accrued interest of $38 thousand.  There are no financial covenants associated with these term loans.  As of June 30, 2015, we were in compliance with all non-financial covenants.